About 1 result found for searched term "Atoltivimab" (0.234 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M24936 | Atoltivimab | Anti-infection |
| REGN3470 | ||
| Atoltivimab (REGN3470), or maftivimab/odesivimab (Inmazeb) is the first Food and Drug Administration (FDA)-approved monoclonal antibody to target Zaire ebolavirus (EBOVs) infection. | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2026 AbMole BioScience. All Rights Reserved.
